Entries by Malin Bergholm

SenzaGen´s share issue oversubscribed – raises MSEK 44

Tue, Oct 06, 2015 08:38 CET SenzaGen has just completed a share issue to accelerate the company’s rapidly growing revenues, scale up the sales organization, complete ongoing validation processes and develop new tests in the GARD portfolio. The interest has been overwhelming which is why the Company, at an Extraordinary General Meeting on Monday, October […]

Andy Forreryd wins a “Best Abstract Presentation Price” about GARD technique

Wed, Jun 17, 2015 06:50 CET Andy Forreryd of the Dept. of Immunotechnology won a “Best Abstract Presentation Price” at the Oral Abstract session entitled Risk factors and biomarkers in occupational allergy held at EAACI 2015 in Barcelona. Andy’s contribution was entitled Prediction of chemical respiratory sensitizers using GARD, a novel in vitro assay based […]